---
$id: https://graph.org.ai/products/commodity/51262702
$type: Product
source: UNSPSC
code: "51262702"
title: "Tymazoline"
class: "51262700"
classTitle: "Adrenergic blocking agent imidazolines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tymazoline

**UNSPSC Code**: 51262702
**Class**: [Adrenergic blocking agent imidazolines](Adrenergic blocking agent imidazolines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C14H20N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U993RH5585, chemically known as 1,4,5-dihydro-2-(2-isopropyl-5-methylphenoxymethyl)imidazol but generally known as tymazoline, which bears US NIH Compound Identifier 34154. European Medicines Agency schedules Tymazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15640MIG. World Health Organization schedules tymazoline in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, TYMAZOLINE remains the US FDA Preferred Term for this commodity. Tymazoline bears US NLM identifiers UMLS ID C0771442 and NCI Concept Code C95309. SMILES: O(C1C(C(C)C)CCC(C1)C)CC1=NCCN1.

